Academia de Patología y Medicina de Laboratorio de Puerto Rico

15/04/2026

Les informamos que se ha extendido hasta el lunes 20 de abril la tarifa de descuento para el 2026 Annual Meeting de la Academia de Patología y Medicina de Laboratorios de Puerto Rico a llevarse a cabo del 2 al 3 de mayo de 2026 en el Royal Sonesta San Juan. Luego de esa fecha aumenta el costo de inscripción. El último día para registrarse es el 26 de abril de 2026.

Puede realizar su registro accediendo al enlace https://2026-apml-annual-meeting.eventbrite.com

Para más información, escribir a patologospr@serrayserra.com

04/02/2026

📣 CALL FOR ABSTRACTS 📣
Have a compelling case or research project to share? Prepare your digital poster and submit it to pracademyofpathology@gmail.com by April 24, 2026.✨

Accepted posters will be showcased on 55-inch monitors in the exhibitor area, looping continuously throughout the session. Each presenter will have 3–5 minutes to highlight their work, followed by a short Q&A.

🏆 Poster Awards will be presented based on:
- Poster content and organization
- Research or case complexity
- Poster appearance and image quality
- Presenter knowledge

We’re excited to see what you’ve been working on!

07/01/2026

La Academia de Patología y Medicina de Laboratorio de Puerto Rico les invita al 2026 Annual Meeting a llevarse a cabo el sábado 2 y domingo 3 de mayo de 2026, en el Royal Soneta San Juan.

Para información, costos de participación y registro favor de acceder a https://2026-apml-annual-meeting.eventbrite.com

04/12/2025

🧬 APML Featured Case Study

Case Highlights:
• High-grade prostatic adenocarcinoma identified through bladder-washing cytology — a rare but clinically impactful finding.
• Cytology revealed atypical glandular clusters prompting evaluation for non-urothelial origin.

Clinical Significance:
This case highlights the importance of recognizing prostatic origin in urinary cytology, ensuring accurate diagnosis and avoiding delays in management.

🔗 Full case:

Bladder washing cytology is a valuable diagnostic tool primarily used in the evaluation of urothelial malignancies. However, its role in detecting metastatic or secondary malignancies, such as high-grade prostatic adenocarcinoma, is less commonly recognized. We present the case of an 82-year-old man...

18/11/2025

📢 ¡1era Edición del BLUE HOPE 5K – San Juan, PR!

Acompáñanos en esta jornada dedicada a crear conciencia sobre el cáncer de próstata.💙

🚶‍♂️🏃‍♀️ Únete a nuestro grupo “Pathology in Motion” o forma el tuyo y participa corriendo o caminando. Cada paso cuenta para promover la detección temprana.

🕢 6:30 AM
📅 13 de diciembre de 2025
📍 Balneario El Escambrón

🔗 Regístrate aquí: bluehope5kpr.com

15/11/2025

Queremos expresar nuestro más sincero agradecimiento por haber asistido ayer a la charla “Transforming the Management of Cancer with Personalized Test”, auspiciada por Natera. Su presencia y participación hicieron de este encuentro un espacio realmente enriquecedor. Esperamos que la información presentada haya sido de gran valor para la comunidad de patología en Puerto Rico.
¡Gracias por acompañarnos!🔬

31/10/2025

La Academia de Patología y Medicina de Laboratorio de Puerto Rico se complace en invitar a todos los patólogos de PR a una charla única e informativa:
“Transforming the management of cancer with personalized test”
🗓️Fecha: 14 de noviembre
⏰ Hora: 6:30 PM
📍 Lugar: Morton’s Steakhouse

La charla será dirigida por los distinguidos Dr. López y Dr. Khan. No te pierdas la oportunidad de actualizarte sobre los avances más recientes en el manejo personalizado del cáncer.

¡Nos encantaría contar con tu presencia!🇵🇷

10/08/2025

Featured Case Study:
Mixed Phenotype Acute Leukemia (T/Myeloid MPAL) with BCR::ABL1 Fusion in a Hispanic Patient

🔍Case Highlights:
A 61-year-old woman presents with generalized lymphadenopathy.

Lymph node biopsy reveals blasts expressing both myeloid (MPO, lysozyme) and T-cell markers (CD3, CD4, CD5, CD7).

Bone marrow confirms MPAL; molecular testing detects the BCR:: ABL1 fusion, a key driver mutation.

💡Clinical Significance:
MPAL is rare, with the T/Myeloid subtype especially challenging due to its mixed lineage and extramedullary presentation. The presence of BCR::ABL1 further complicates treatment strategies.

This case showcases the necessity of integrated diagnostics— combining morphology, immunophenotyping, and molecular assays— to guide targeted therapy and improve patient outcomes.

Thanks to Dr. Camille Santiago for this incredible paper!
• Full Case (Open Access): https://pubmed.ncbi.nlm.nih.gov/40605863/

02/07/2025

In a recent Cancer Cytopathology publication, several of our members demonstrate that digital cytopathology, especially with the Techcyte SureView™ system, can markedly improve laboratory workflow and operational efficiency.🇵🇷🔬

Access the full publication here: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.70019

11/06/2025

📚 Pathology Spotlight
A recently published case from one our members in Cureus details an incidental finding of re**al malakoplakia in a patient with Crohn’s disease 🌟
⠀
🔍 Key points for pathologists:
• Rare association – malakoplakia typically linked to immunosuppression/infection
• Diagnostic pitfalls – can mimic neoplastic or granulomatous lesions
• The importance of clinical context in IBD-related histopathology
⠀
✅ Takeaway: When encountering unusual histological features in Crohn’s specimens, think beyond the expected. Keeping malakoplakia in the differential can guide proper management.


Access the full text here: https://www.cureus.com/articles/369597-a-case-of-re**al-malakoplakia-associated-with-crohns-disease-an-incidental-finding #!/

12/05/2025

¡Presentamos con orgullo a nuestra nueva directiva! ✨🔬

La Academia de Patología y Medicina de Laboratorio de Puerto Rico se complace en anunciar la elección de su nueva directiva para el periodo 2025-2027. Agradecemos su compromiso, liderazgo y dedicación para continuar fortaleciendo nuestra comunidad académica y profesional.